Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations - PubMed (original) (raw)

Review

. 2014 Sep;23(9):891-901.

doi: 10.1002/pds.3674. Epub 2014 Jun 24.

Affiliations

Review

Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations

Dae Hyun Kim et al. Pharmacoepidemiol Drug Saf. 2014 Sep.

Abstract

Purpose: Geriatric frailty is a common syndrome of older adults that is characterized by increased vulnerability to adverse health outcomes and influences treatment choice. Pharmacoepidemiologic studies that rely on administrative claims data in older adults are limited by confounding due to unmeasured frailty. A claims-based frailty score may be useful to minimize confounding by frailty in such databases. We provide an overview of definitions and measurement of frailty, evaluated the claims-based models of frailty in literature, and recommend ways to improve frailty adjustment in claims analysis.

Methods: We searched MEDLINE and EMBASE from inception to April 2014, without language restriction, to identify claims-based multivariable models that predicted frailty or its related outcome, disability. We critically appraised their approach, including population, predictor selection, outcome definition, and model performance.

Results: Of 152 reports, three models were identified. One model that predicted poor functional status using healthcare service claims in a representative sample of community-dwelling and institutionalized older adults showed an excellent discrimination (C statistic, 0.92). The other two models that predicted disability using either diagnosis codes or prescription claims alone in institutionalized or frail adults had limited generalizability and modest model performance. None of the models have been applied to reduce confounding bias in pharmacoepidemiologic studies of drug therapy.

Conclusions: We found little research conducted on development and application of a claims-based frailty index for confounding adjustment in pharmacoepidemiologic studies in older adults. More research is needed to advance this innovative, potentially useful approach by incorporating the expertise from aging research.

Keywords: administrative claims database; frailty; pharmacoepidemiology; prediction.

Copyright © 2014 John Wiley & Sons, Ltd.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Dr. Kim has no disclosure. Dr. Schneeweiss is a consultant to WHISCON, LLC and to Aetion, Inc., a software manufacturer of which he owns shares. He is principal investigator of investigator-initiated grants to the Brigham and Women’s Hospital from Novartis and Boehringer-Ingelheim unrelated to the topic of this study.

Figures

Figure

Figure. The Relationship Among Frailty, Comorbidity, and Disability in the Cardiovascular Health Study (Reprinted with permission)

Percents listed indicate the proportion among those who were frail (n = 368), who had comorbidity and/or disability, or neither. Total represented: 2,762 participants who had comorbidity and/or disability and/or frailty. n of each subgroup indicated in parentheses. +Frail: overall n = 368 frail participants. *Comorbidity: overall n = 2,576 with 2 or more out of the following 9 diseases: myocardial infarction, angina, congestive heart failure, claudication, arthritis, cancer, diabetes, hypertension, chronic obstructive pulmonary disease. Of these, 249 were also frail. **Disabled: overall n = 363 with an ADL disability; of these, 100 were frail.

Similar articles

Cited by

References

    1. Ray WA. Observational studies of drugs and mortality. N Engl J Med. 2005 Dec 1;353(22):2319–2321. - PubMed
    1. McGrath LJ, Cole SR, Kshirsagar AV, Weber DJ, Sturmer T, Brookhart MA. Hospitalization and skilled nursing care are predictors of influenza vaccination among patients on hemodialysis: evidence of confounding by frailty. Med Care. 2013 Dec;51(12):1106–1113. - PMC - PubMed
    1. Glynn RJ, Knight EL, Levin R, Avorn J. Paradoxical relations of drug treatment with mortality in older persons. Epidemiology. 2001 Nov;12(6):682–689. - PubMed
    1. Sturmer T, Schneeweiss S, Brookhart MA, Rothman KJ, Avorn J, Glynn RJ. Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol. 2005 May 1;161(9):891–898. - PMC - PubMed
    1. Dormuth CR, Patrick AR, Shrank WH, et al. Statin adherence and risk of accidents: a cautionary tale. Circulation. 2009 Apr 21;119(15):2051–2057. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources